LAWRENCE HESS: Open Payments
NPI 1720176217 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 33 payments from 8 companies in 2025. Trend: 2023 $615 · 2024 $800 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $187 |
| Lilly USA, LLC | 1 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| TOLMAR, INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $18 |
| BETA BIONICS, INC. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: NURTEC ODT, ZEPBOUND, FARXIGA, AIRSUPRA, JATENZO, REXULTI, FREESTYLE LIBRE, iLet Bionic Pancreas.
Industry payments across TX — which companies pay providers there.
